- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Severe active rheumatoid arthritis
- Meeting Date: July 2009
- Public Summary Document (PSD) July 2009 PBAC Meeting - PDF
Tocilizumab – July 2009
Tocilizumab, solution for I.V. infusion, 80 mg in 4 mL, 200 mg in 10 mL and 400 mg in 20 mL, Actemra®, July 2009
Last updated
30 October 2009